Equity–AsiaResearchPresentation:医药行业企改革报告:企改革正当时,船到中流当奋楫State-OwnedEnterpriseReforminthePharmaceuticalIndustry:TheRightTimeforReform,NavigatingMidstreamwithDetermination余...
[Table_Page]公司深度研究保险Ⅱ证券研究报告【广[Table_Title]发非银&海外】中国太平[公Tab司le_I评nves级t]买入(00966.HK)当前价格8.55港元合理价值13.51港元报告日期2024-06-14核心观点:[Table_Summary]资...